Skip to Main Content
April 28, 2020

Health Law Daily

Home Health Agencies Call For Change To Some Medicare Benefits To Allow More Patients To Get IV Drugs At Home During Pandemic

  • April 28, 2020

Bloomberg Law (4/28, Lee, Subscription Publication) reports “home health agencies and lawmakers are calling for a policy change to certain Medicare benefits to let more patients who need lifesaving IV drugs get those medications at home during the coronavirus outbreak.” The piece says “enabling more at-home drug infusions would protect people at high risk for severe complications, such as the elderly or immuno-compromised, and help hospitals around the country clear space for Covid-19 patients.” According to Bloomberg Law, “Drugs covered by Medicare’s outpatient drug network...don’t have a home infusion benefit, ‘which severely limits Medicare beneficiary access to these home infusion drugs,’ nine health care systems told CMS Administrator Seema Verma earlier this month.”